|
1
|
Arora T, Mullangi S, Vadakekut ES and
Lekkala MR: Epithelial ovarian cancer. StatPearls Treasure Island
(FL): StatPearls Publishing; 2025
|
|
2
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2018: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 68:297–316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen
Y, Lin D and Wu C: Tumor initiation and early tumorigenesis:
Molecular mechanisms and interventional targets. Signal Transduct
Target Ther. 9:1492024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng Y, Wang Y, Zhou C, Mei W and Zeng C:
PI3K/Akt/mTOR pathway and its role in cancer therapeutics: Are we
making headway? Front Oncol. 12:8191282022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mishra R, Patel H, Alanazi S, Kilroy MK
and Garrett JT: PI3K inhibitors in cancer: Clinical implications
and adverse effects. Int J Mol Sci. 22:34642021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang M, Zhang H, Lu Z, Su W, Tan Y, Wang J
and Jia X: PSAT1 mediated EMT of colorectal cancer cells by
regulating Pl3K/AKT signaling pathway. J Cancer. 15:3183–3198.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Li J, Dong X, Meng D, Zhi X, Yuan
L and Yao L: PSAT1 regulated oxidation-reduction balance affects
the growth and prognosis of epithelial ovarian cancer. Onco Targets
Ther. 13:5443–5453. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng MJ, Li X, Hu YX, Dong H, Gou R, Nie
X, Liu Q, Ying-Ying H, Liu JJ and Lin B: Identification of
molecular marker associated with ovarian cancer prognosis using
bioinformatics analysis and experiments. J Cell Physiol.
234:11023–11036. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu B, Jia Y, Cao Y, Wu S, Jiang H, Sun X,
Ma J, Yin X, Mao A and Shang M: Overexpression of phosphoserine
aminotransferase 1 (PSAT1) predicts poor prognosis and associates
with tumor progression in human esophageal squamous cell carcinoma.
Cell Physiol Biochem. 39:395–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vié N, Copois V, Bascoul-Mollevi C, Denis
V, Bec N, Robert B, Fraslon C, Conseiller E, Molina F, Larroque C,
et al: Overexpression of phosphoserine aminotransferase PSAT1
stimulates cell growth and increases chemoresistance of colon
cancer cells. Mol Cancer. 7:142008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pollari S, Käkönen SM, Edgren H, Wolf M,
Kohonen P, Sara H, Guise T, Nees M and Kallioniemi O: Enhanced
serine production by bone metastatic breast cancer cells stimulates
osteoclastogenesis. Breast Cancer Res Treat. 125:421–430. 2011.
View Article : Google Scholar
|
|
12
|
Li H, Wu C, Chang W, Zhong L, Gao W, Zeng
M, Wen Z, Mai S and Chen Y: Overexpression of PSAT1 is correlated
with poor prognosis and immune infiltration in non-small cell lung
cancer. Front Biosci (Landmark Ed). 28:2432023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45(W1):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cancer Genome Atlas Research Network:
Integrated genomic analyses of ovarian carcinoma. Nature.
474:609–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
GTEx Consortium: Human genomics. The
genotype-tissue expression (GTEx) pilot analysis: Multitissue gene
regulation in humans. Science. 348:648–660. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Messeguer X, Escudero R, Farré D, Núñez O,
Martínez J and Albà MM: PROMO: detection of known transcription
regulatory elements using species-tailored searches.
Bioinformatics. 18:333–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sandelin A and Wasserman WW: Constrained
binding site diversity within families of transcription factors
enhances pattern discovery bioinformatics. J Mol Biol. 338:207–215.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sirr A, Lo RS, Cromie GA, Scott AC,
Ashmead J, Heyesus M and Dudley AM: A yeast-based complementation
assay elucidates the functional impact of 200 missense variants in
human PSAT1. J Inherit Metab Dis. 43:758–769. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van der Crabben SN, Verhoeven-Duif NM,
Brilstra EH, Van Maldergem L, Coskun T, Rubio-Gozalbo E, Berger R
and de Koning TJ: An update on serine deficiency disorders. J
Inherit Metab Dis. 36:613–619. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo MY, Zhou Y, Gu WM, Wang C, Shen NX,
Dong JK, Lei HM, Tang YB, Liang Q, Zou JH, et al: Metabolic and
nonmetabolic functions of PSAT1 coordinate signaling cascades to
confer EGFR inhibitor resistance and drive progression in lung
adenocarcinoma. Cancer Res. 82:3516–3531. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang SP, Chan YC, Huang SY and Lin YF:
Overexpression of PSAT1 gene is a favorable prognostic marker in
lower-grade gliomas and predicts a favorable outcome in patients
with IDH1 mutations and chromosome 1p19q Codeletion. Cancers
(Basel). 12:132019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Acuna-Hidalgo R, Schanze D, Kariminejad A,
Nordgren A, Kariminejad MH, Conner P, Grigelioniene G, Nilsson D,
Nordenskjöld M, Wedell A, et al: Neu-Laxova syndrome is a
heterogeneous metabolic disorder caused by defects in enzymes of
the L-serine biosynthesis pathway. Am J Hum Genet. 95:285–293.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moat S, Carling R, Nix A, Henderson M,
Briddon A, Prunty H, Talbot R, Powell A, Wright K, Fuchs S and de
Koning T: Multicentre age-related reference intervals for
cerebrospinal fluid serine concentrations: Implications for the
diagnosis and follow-up of serine biosynthesis disorders. Mol Genet
Metab. 101:149–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liao KM, Chao TB, Tian YF, Lin CY, Lee SW,
Chuang HY, Chan TC, Chen TJ, Hsing CH, Sheu MJ and Li CF:
Overexpression of the PSAT1 gene in nasopharyngeal carcinoma is an
indicator of poor prognosis. J Cancer. 7:1088–1094. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Marchi T, Timmermans MA, Sieuwerts AM,
Smid M, Look MP, Grebenchtchikov N, Sweep FCGJ, Smits JG, Magdolen
V, van Deurzen CHM, et al: Phosphoserine aminotransferase 1 is
associated to poor outcome on tamoxifen therapy in recurrent breast
cancer. Sci Rep. 7:20992017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qian C, Xia Y, Ren Y, Yin Y and Deng A:
Identification and validation of PSAT1 as a potential prognostic
factor for predicting clinical outcomes in patients with colorectal
carcinoma. Oncol Lett. 14:8014–8020. 2017.
|
|
27
|
Jia L, Li D, Wang YN, Zhang D and Xu X:
PSAT1 positively regulates the osteogenic lineage differentiation
of periodontal ligament stem cells through the
ATF4/PSAT1/Akt/GSK3β/β-catenin axis. J Transl Med. 21:702023.
View Article : Google Scholar
|
|
28
|
Fang Y, Liang X, Xu J and Cai X: miR-424
targets AKT3 and PSAT1 and has a tumor-suppressive role in human
colorectal cancer. Cancer Manag Res. 10:6537–6547. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duan W and Liu X: PSAT1 upregulation
contributes to cell growth and cisplatin resistance in cervical
cancer cells via regulating PI3K/AKT signaling pathway. Ann Clin
Lab Sci. 50:512–518. 2020.PubMed/NCBI
|
|
30
|
Hui Z, Wang X and Li X: Targeting the
serine-glycine one-carbon pathway overcomes glutathione-mediated
drug resistance in cancer. Cell Death Dis. 10:522019.
|
|
31
|
Moloney JN and Cotter TG: ROS signalling
in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018.
View Article : Google Scholar
|
|
32
|
Smith CL, Bolton A and Nguyen G: Genomic
and epigenomic instability, fragile sites, schizophrenia and
autism. Curr Genomics. 11:447–469. 2010. View Article : Google Scholar
|
|
33
|
Butturini E, Carcereri de Prati A, Boriero
D and Mariotto S: Natural sesquiterpene lactones enhance
chemosensitivity of tumor cells through redox regulation of STAT3
signaling. Oxid Med Cell Longev. 2019:45689642019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lv H, Zhen C, Liu J, Yang P, Hu L and
Shang P: Unraveling the potential role of glutathione in multiple
forms of cell death in cancer therapy. Oxid Med Cell Longev.
2019:31501452019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao S, Ge A, Xu S, You Z, Ning S, Zhao Y
and Pang D: PSAT1 is regulated by ATF4 and enhances cell
proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway
in ER-negative breast cancer. J Exp Clin Cancer Res. 36:1792017.
View Article : Google Scholar
|
|
36
|
Jia Q, Yan S, Huang J and Xu S: Restored
microRNA-133a-3p or depleted PSAT1 restrains endothelial cell
damage-induced intracranial aneurysm via suppressing the
GSK3β/β-catenin pathway. Nanoscale Res Lett. 15:1772020. View Article : Google Scholar
|
|
37
|
Wang H, Fang Q, You S, Wu Y and Zhang C:
miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast
cancer cells. Genes Genomics. 45:39–47. 2023. View Article : Google Scholar
|
|
38
|
Wang H, Cui L, Li D, Fan M, Liu Z, Liu C,
Pan S, Zhang L, Zhang H and Zhao Y: Overexpression of PSAT1
regulated by G9A sustains cell proliferation in colorectal cancer.
Signal Transduct Target Ther. 5:472020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang G, Chen JH, Qiang Y, Wang DZ and Chen
Z: Decreased STAT4 indicates poor prognosis and enhanced cell
proliferation in hepatocellular carcinoma. World J Gastroenterol.
21:3983–3993. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang Y, Xin X, Pan X, Zhang A, Zhang Z,
Li J and Yuan X: STAT4 targets KISS1 to promote the apoptosis of
ovarian granulosa cells. J Ovarian Res. 13:1352020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu L, Wei J and Liu P: Attacking the
PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment
in human cancer. Semin Cancer Biol. 85:69–94. 2022. View Article : Google Scholar
|
|
42
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer:
Biological and therapeutic significance. Semin Cancer Biol.
59:147–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wymann MP and Pirola L: Structure and
function of phosphoinositide 3-kinases. Biochim Biophys Acta.
1436:127–150. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Quambusch L, Depta L, Landel I, Lubeck M,
Kirschner T, Nabert J, Uhlenbrock N, Weisner J, Kostka M and Levy
LM: Cellular model system to dissect the isoform-selectivity of Akt
inhibitors. Nat Commun. 12:52972021. View Article : Google Scholar : PubMed/NCBI
|
